Sigyn Therapeutics (OTCMKTS:SIGY) Trading Up 1.2% – Here’s What Happened

Sigyn Therapeutics, Inc. (OTCMKTS:SIGY)’s stock price traded up 1.2% during mid-day trading on Thursday . The stock traded as high as $4.15 and last traded at $4.15. 2,003 shares were traded during trading, an increase of 301% from the average session volume of 500 shares. The stock had previously closed at $4.10.

Sigyn Therapeutics Price Performance

The business has a 50-day simple moving average of $3.68 and a 200 day simple moving average of $4.56.

About Sigyn Therapeutics

Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.